The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

APO-go POD 5 mg/ml solution for infusion in cartridge

Stada Arzneimittel AGPA0593/042/004

Main Information

Trade NameAPO-go POD 5 mg/ml solution for infusion in cartridge
Active SubstancesApomorphine hydrochloride hemihydrate
Dosage FormSolution for infusion in cartridge
Licence HolderStada Arzneimittel AG
Licence NumberPA0593/042/004

Group Information

ATC CodeN04BC07 apomorphine


License statusAuthorised
Licence Issued13/11/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back